Janus Henderson Global Life Sciences Fund Class D (JNGLX) Fund Details & Analysis

Fund Information

Fund Category Health

Fund Family Janus Henderson

Fund Style Large Blend

ISIN US47103E7004

CUSIP 47103E700

Inception Date -

Domicile -

Country USA

Fiscal Year End -

NAV Chart

Fund Metrics

Net Assets $4.11 Billion

Share Class Net Assets $-

Expense Ratio 0.80%

Expense Ratio Date -

Dividend Yield 0.00%

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Performance

YTD Return 1.79%

1-Year Return 26.35%

3-Year Return 11.91%

5-Year Return 7.57%

NAV $83.03

Previous Close Price $82.05

Last Update 2025-12-31

Dividend Information

Dividend Yield 0.00%

Dividend (ttm) 0.17

Dividend Growth -58.12%

Payout Frequency Annual

Ex-Dividend Date n/a

Ratings

Morning Star Rating -

Morning Star Risk Rating -

Morning Star Category -

Beta (5Y) 1.23

About Janus Henderson Global Life Sciences Fund Class D

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio management believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.

Detailed Metrics

Market Cap Distribution

AverageMarketCap 68604.21%

Giant 20.08%

Large 38.85%

Medium 11.46%

Micro 5.64%

Small 19.53%

Value & Growth Metrics

Book-Value Growth % 8.42%

Cash-Flow Growth % -7.38%

Dividend Yield % 1.22%

Historical Earnings % 1.63%

Long-Term Earnings % 11.04%

Asset Allocation

Type	Net %	Long %	Short %	Category Average	benchmark
Bond	0.00%	0.00%	0.00%	0.18%	0.00%
Cash	0.61%	0.61%	0.00%	1.44%	0.00%
Non US Stock	14.82%	14.82%	0.00%	8.38%	0.23%
Not Classified	0.87%	0.87%	0.00%	0.00%	0.00%
Other	0.54%	0.54%	0.00%	0.14%	0.00%
US Stock	83.16%	83.16%	0.00%	90.06%	99.77%

Top Holdings

Name	Weight	Owned	Change
Eli Lilly Co. COM NPV	8.31%	-	-
UnitedHealth Group Inc. COM USD0.01	4.21%	-	-
Novo Nordisk A/S SER'B'DKK0.1	5.95%	-	-
AstraZeneca PLC ORD USD0.25	4.22%	-	-
AbbVie Inc. COM USD0.01	3.58%	-	-
Merck Co., Inc COM USD0.50	3.28%	-	-
Amgen Inc. COM USD0.0001	2.89%	-	-
Sanofi EUR2	3.05%	-	-
Boston Scientific Corporation COM USD0.01	2.74%	-	-
Vertex Pharmaceuticals Incorporated COM USD0.01	2.81%	-	-
Johnson Johnson COM USD1.00	5.01%	-	-
Abbott Laboratories COM NPV	3.16%	-	-
Argenx SE SPON ADR EACH REP 1 ORD SHS	2.82%	-	-
Sanofi SA EUR2	2.69%	-	-
Novartis AG ADR-REP 1 CHF0.5 (REGD)	2.56%	-	-

See the full breakdown of JNGLX fund's asset allocation and top holdings .

Sector Weights

Category	Subcategory	Amount %	Category Avg	Stocks %	Benchmark
Bond Sector	Cash and Equivalents	0.00%	88.82%	41.37%	0.00%
Bond Sector	Corporate	0.00%	11.18%	58.63%	0.00%
Bond Sector	Derivative	0.00%	0.00%	0.00%	0.00%
Bond Sector	Government	0.00%	0.00%	0.00%	0.00%
Bond Sector	Municipal	0.00%	0.00%	0.00%	0.00%
Bond Sector	Securitized	0.00%	0.00%	0.00%	0.00%
Cyclical	Basic Materials	0.00%	0.00%	0.00%	0.00%
Cyclical	Consumer Cyclical	0.00%	0.00%	0.00%	0.00%
Cyclical	Financial Services	0.00%	0.02%	0.00%	0.00%
Cyclical	Real Estate	0.00%	0.14%	0.00%	0.00%
Defensive	Consumer Defensive	0.00%	0.00%	0.00%	0.00%
Defensive	Healthcare	100.00%	99.80%	0.00%	100.00%
Defensive	Utilities	0.00%	0.00%	0.00%	0.00%
Sensitive	Communication Services	0.00%	0.00%	0.00%	0.00%
Sensitive	Energy	0.00%	0.02%	0.00%	0.00%
Sensitive	Industrials	0.00%	0.01%	0.00%	0.00%
Sensitive	Technology	0.00%	0.00%	0.00%	0.00%

World Regions

Region	Subregion	Category Average	Stocks Percent	Benchmark
Americas	Latin America	-	-	-
Americas	North America	91.79%	85.15%	99.77%
Greater Asia	Asia Developed	0.09%	-	-
Greater Asia	Asia Emerging	0.10%	0.31%	-
Greater Asia	Australasia	0.07%	-	-
Greater Asia	Japan	0.40%	0.83%	-
Greater Europe	Africa/Middle East	0.26%	0.87%	-
Greater Europe	Europe Developed	5.28%	8.60%	0.10%
Greater Europe	Europe Emerging	-	-	-
Greater Europe	United Kingdom	2.01%	4.24%	0.13%

Dividend History

Date	Amount	Unadjusted Amount	Currency	Declaration Date	Record Date	Payment Date	Period
2024-12-06	$0.248	$0.248	USD	-	-	-	-
2023-12-07	$0.093	$0.093	USD	-	2023-12-06	2023-12-07	Annual
2022-12-20	$0.171	$0.171	USD	2022-12-20	2022-12-19	2022-12-20	Annual
2021-12-20	$0.871	$0.871	USD	2021-12-20	2021-12-17	2021-12-20	Annual
2020-12-17	$0.755	$0.755	USD	2020-12-17	2020-12-16	2020-12-17	Annual
2019-12-17	$0.500	$0.500	USD	2019-12-17	2019-12-16	2019-12-17	Other
2018-12-18	$0.000	$0.000	None	-	-	-	-
2017-12-19	$0.205	$0.205	USD	2017-12-19	2017-12-18	2017-12-19	Other
2016-12-19	$0.134	$0.134	USD	2016-12-19	2016-12-16	2016-12-19	Annual
2015-12-17	$0.166	$0.166	USD	2015-12-17	2015-12-16	2015-12-17	Other
2014-12-17	$0.000	$0.000	None	-	-	-	-
2013-12-17	$0.000	$0.000	None	-	-	-	-
2012-12-18	$0.000	$0.000	None	-	-	-	-
2011-12-20	$0.037	$0.037	USD	-	2011-12-19	2011-12-20	Annual
2010-12-22	$0.120	$0.120	USD	-	2010-12-21	2010-12-22	Other
2009-12-22	$0.002	$0.000	None	-	-	-	-
2009-06-24	$0.036	$0.000	None	-	-	-	-
2008-12-12	$0.027	$0.000	None	-	-	-	-
2000-12-15	$0.016	$0.000	None	-	-	-	-

Janus Henderson Global Life Sciences Fund Class D NMFQS:JNGLX